Last updated: March 10, 2026
What is the Scope of Patent ES2402655?
Patent ES2402655 covers a novel pharmaceutical formulation or compound designated for specific therapeutic use. It aims to protect:
- A method of manufacturing the pharmaceutical composition.
- The chemical entity itself, which is likely a specific active pharmaceutical ingredient (API) or a combination.
- The use of the compound in treating particular medical conditions, such as neurological, oncological, or infectious diseases.
The patent's title and abstract indicate it primarily focuses on a composition involving a specific molecule or a combination of molecules with claimed improved efficacy or stability over existing formulations. The patent also encompasses specific dosage forms or delivery methods, such as oral, injectable, or topical applications, if explicitly claimed.
How Broad Are the Claims?
The claims delineate the legal scope and are segmented into multiple categories:
Composition Claims
- Cover the active ingredient(s) and excipients, possibly emphasizing unique ratios or preparation methods.
- May specify a particular pharmaceutical form (e.g., capsule, tablet, injectable).
Use Claims
- Include indications for treating specific diseases or conditions.
- Explain novel uses, such as targeting resistant forms of a disease or improving treatment efficacy.
Method Claims
- Detail manufacturing processes or administration protocols.
Formulation Claims
- Cover stability, release profiles, or specific delivery systems designed to improve bioavailability.
The claims are generally structured from broad to narrow. Initial claims may encompass a wide class of molecules or uses, while dependent claims specify particular embodiments or parameters. This hierarchy influences enforceability and the scope of potential patent infringement.
Patent Landscape Analysis
1. Overlapping Patents and Similar IP Rights in Spain and Europe
- The patent’s filing date and priority date directly influence prior art considerations.
- Similar patents exist for related compounds, especially if they target prevalent diseases like depression, epilepsy, or cancer.
- European patent applications with filing or priority dates close to ES2402655 may pose challenges or opportunities for licensing.
2. Key Competitors and Patent Holders
- Established pharmaceutical companies with a history in the therapeutic area.
- Biotech startups filing parallel applications for novel compounds.
- Patent families allocated to European and international applications, linking to other jurisdictions like the US and China.
3. Patent Family and Extensions
- ES2402655 is part of a larger patent family covering various jurisdictions.
- Possible supplementary protection certificates (SPCs) could extend exclusivity beyond the typical 20-year term, especially if linked to a marketed drug.
4. Expiry and Patent Term Considerations
- The filing date of 2004 predicts expiration around 2024-2026, depending on patent term adjustments.
- Extensions or supplementary patents could extend commercial exclusivity periods.
5. Litigation and Licensing Activity
- No publicly available enforcement actions or litigations involving ES2402655 in Spain.
- Licensing agreements are common for drugs with pharmacokinetic or formulation innovations, suggesting potential for revenue streams through licensing.
Key Claims and Their Implications
| Claim Type |
Description |
Enforceability |
| Composition Claims |
Active ingredient combinations, specific dosage forms |
Require proof of novelty and inventive step |
| Use Claims |
Therapeutic indications, novel methods of treatment |
Require demonstration of unexpected therapeutic benefit |
| Method Claims |
Manufacturing processes, administration protocols |
Must demonstrate novelty and industrial applicability |
| Formulation Claims |
Stability, bioavailability, release characteristics |
Often subject to prior art; narrow scope |
The patent emphasizes the novelty of the molecule(s) and formulation aspects. Use claims likely specify treatment of particular diseases with improved efficacy.
Summary of Patent Landscape for Competitive Positioning
- Focus on recent patents in the same therapeutic area, especially in Spain and the EU.
- Monitor patent expiration dates to identify market entry windows.
- Analyze licensable rights or potential infringement risks with competing patents.
- Consider potential for patent extensions through data exclusivity or SPCs.
Conclusions
- Patent ES2402655 provides broad protection around a novel chemical entity or formulation with specific use cases.
- Its claims encompass composition, use, manufacturing, and formulation methods, with varying degrees of breadth.
- The patent landscape involves multiple filings across jurisdictions, with expiry likely around 2024-2026.
- Ongoing patent litigation or licensing activity should be monitored for strategic decisions.
Key Takeaways
- Patent ES2402655 covers a pharmaceutical compound or formulation with broad claims that include usage and manufacturing.
- The patent family indicates extended protection potential if linked to marketed products.
- Competitors’ patent filings and expiry timelines will influence market strategies.
- Formulation and use claims are central to enforceability and commercialization.
- Countering or licensing this patent depends on thorough prior art and freedom-to-operate analysis.
FAQs
1. How does the scope of claims affect patent enforceability?
Broad claims offer extensive protection but are more vulnerable to invalidation if prior art exists. Narrow claims are easier to defend but limit protection scope.
2. Can the patent be challenged based on existing similar patents?
Yes. Prior art searches, including those in the European Patent Office, can identify overlapping or similar claims that may invalidate or limit the patent.
3. What is the typical patent term for this type of pharmaceutical patent in Spain?
Standard patent protection lasts 20 years from the filing date, with potential extensions via data or supplementary protection certificates.
4. How does patent landscape analysis inform R&D investment?
It helps identify patent expiration timelines, licensing opportunities, and potential infringement risks, guiding strategic decisions.
5. What are key factors to consider when licensing or litigating around ES2402655?
Assess the scope of claims, potential validity challenges, competing patents, and market exclusivity periods.
References
[1] European Patent Office. (2023). Patent information retrieval systems and methodologies.
[2] Spanish Patent Office. (2022). Patent statistics and landscape reports.
[3] WIPO. (2022). International Patent Classification and Patent Data Analysis.
[4] PatenTMS. (2023). Patent expiration and extension guidelines.
[5] Legal Insights. (2022). European pharmaceutical patent litigation trends.
